# FDA Warning Letter: Alchymars ICM SM Private Limited
> 2026-05-26 · Center for Drug Evaluation and Research (CDER) · `d1d84fa74d93bf64`
## Letter
- **Company:** Alchymars ICM SM Private Limited
- **Posted Date:** 2026-05-26
- **Letter Issue Date:** 2026-05-21
- **Issuing Office:** Center for Drug Evaluation and Research (CDER)
## Subject
CGMP/Active Pharmaceutical Ingredient (API)/Adulterated
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · MORVS · CC0 1.0*